Stroke: the way things really are.
- 1 June 1994
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 25 (6), 1290-1294
- https://doi.org/10.1161/01.str.25.6.1290
Abstract
To comply with governmental requirements regarding the validity of therapeutic modalities and for medico-legal purposes, it is important to distinguish between what has been scientifically proven and what is anecdotal in the prevention and management of stroke. This review summarizes the evidence for many of the modalities used to prevent stroke in high-risk patients, including antiplatelet drugs, anticoagulants, and endarterectomy, and the limitations of each. Controversial therapeutic modalities for which no scientific proof exists, such as anticoagulation of progressing stroke, are also discussed. The term "standard of care" should apply to modalities proven to be effective by scientifically controlled studies, not because they are used by many physicians. Treatment of acute stroke is still disappointing despite the development of many promising pharmacological strategies in experimental animals. An important part of the reason may be that the window of therapeutic opportunity is much shorter than the usual entry time of patients in most clinical trials. This logistic problem merits serious attention. Numerous controlled, randomized, multiple-center clinical trials have demonstrated that the efficacy or lack thereof of various therapies directed at preventing or treating stroke can be determined and that anecdotal data may be misleading and harmful. At the least we should be aware of what we know and what we do not.This publication has 42 references indexed in Scilit:
- Efficacy of Carotid Endarterectomy for Asymptomatic Carotid StenosisThe New England Journal of Medicine, 1993
- Carotid surgery versus medical therapy in asymptomatic carotid stenosis. The CASANOVA Study Group.Stroke, 1991
- MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosisThe Lancet, 1991
- Intracerebral hemorrhage in stroke patients anticoagulated with heparin.Stroke, 1989
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsThe New England Journal of Medicine, 1989
- Identification and entry of the patient with acute cerebral infarctionAnnals of Emergency Medicine, 1988
- The Natural History of Lone Atrial FibrillationThe New England Journal of Medicine, 1987
- Outcome in Patients with Asymptomatic Neck BruitsThe New England Journal of Medicine, 1986
- Risk of Stroke in Asymptomatic Persons with Cervical Arterial BruitsThe New England Journal of Medicine, 1980
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeThe New England Journal of Medicine, 1978